| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $646,551 ) |
| | 2024 | 2024 | BERKELEY MADONNA, INC. | 1025 PERALTA AVE | ALBANY | CA | 94706-2401 | ALAMEDA | USA | R01AG081466 | Long-Term Approaches to Treating Osteoporosis | 000 | 2 | NIH | 8/1/2024 | $215,606 |
| | 2024 | 2024 | BERKELEY MADONNA, INC. | 1025 PERALTA AVE | ALBANY | CA | 94706-2401 | ALAMEDA | USA | R44LM014480 | Quantitative Modeling Software with Applications to Medical Decision Making | 000 | 2 | NIH | 9/6/2024 | $430,945 |
|
| Issue Date FY: 2023 ( Subtotal = $643,045 ) |
| | 2023 | 2023 | BERKELEY MADONNA, INC. | 1025 PERALTA AVE | ALBANY | CA | 94706-2401 | ALAMEDA | USA | R44LM014480 | Quantitative Modeling Software with Applications to Medical Decision Making | 000 | 1 | NIH | 9/13/2023 | $220,215 |
| | 2023 | 2023 | BERKELEY MADONNA, INC. | 1025 PERALTA AVE | ALBANY | CA | 94706-2401 | ALAMEDA | USA | R01AG081466 | Long-Term Approaches to Treating Osteoporosis | 000 | 1 | NIH | 9/21/2023 | $222,998 |
| | 2023 | 2023 | BERKELEY MADONNA, INC. | 1025 PERALTA AVE | ALBANY | CA | 94706-2401 | ALAMEDA | USA | R44LM014480 | Quantitative Modeling Software with Applications to Medical Decision Making | 000 | 1 | NIH | 9/13/2023 | $199,832 |
|
| Issue Date FY: 2022 ( Subtotal = $0 ) |
| | 2022 | 2019 | BERKELEY MADONNA, INC. | 1025 PERALTA AVE | ALBANY | CA | 94706-2401 | ALAMEDA | USA | R43LM013133 | Quantitative Modeling Software with Applications to Medical Decision Making | 000 | 1 | NIH | 2/7/2022 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $326,600 ) |
| | 2019 | 2019 | BERKELEY MADONNA, INC. | 1135 SPRUCE ST | BERKELEY | CA | 94707-2629 | ALAMEDA | USA | R43LM013133 | Quantitative Modeling Software with Applications to Medical Decision Making | 000 | 1 | NIH | 8/5/2019 | $326,600 |
|
| Issue Date FY: 2018 ( Subtotal = $183,600 ) |
| | 2018 | 2018 | BERKELEY MADONNA, INC. | 1135 SPRUCE ST | BERKELEY | CA | 94707-2629 | ALAMEDA | USA | K08DK114548 | Role of Ceramide in Hepatic Stellate Cell Activation and Liver Fibrosis | 000 | 2 | NIH | 7/27/2018 | $183,600 |
|
| Issue Date FY: 2017 ( Subtotal = $185,100 ) |
| | 2017 | 2017 | BERKELEY MADONNA, INC. | 1135 SPRUCE ST | BERKELEY | CA | 94707-2629 | ALAMEDA | USA | K08DK114548 | Role of Ceramide in Hepatic Stellate Cell Activation and Liver Fibrosis | 000 | 1 | NIH | 9/1/2017 | $185,100 |
|
|
